The Challenges and Optimization of Cell-based Therapy for Cardiovascular Disease

Overview

Journal J Transl Int Med

Publisher Sciendo

Specialty General Medicine

Date 2022 Feb 9

PMID 35136722

Authors

Shiyue Xu

Yumin Qiu

Jun Tao

Affiliations

Soon will be listed here.

Abstract

With the hope of achieving real cardiovascular repair, cell-based therapy raised as a promising strategy for the treatment of cardiovascular disease (CVD) in the past two decades. Various types of cells have been studied for their reparative potential for CVD in the ensuing years. Despite the exciting results from animal experiments, the outcome of clinical trials is unsatisfactory and the development of cell-based therapy for CVD has hit a plateau nowadays. Thus, it is important to summarize the obstacles we are facing in this field in order to explore possible solutions for optimizing cell-based therapy and achieving real clinical application.

Citing Articles

Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics.

Kumar R, Mishra N, Tran T, Kumar M, Vijayaraghavalu S, Gurusamy N Cells. 2024; 13(10.

PMID: 38786076 PMC: 11120430. DOI: 10.3390/cells13100855.

Exosomes-mediated drug delivery for the treatment of myocardial injury.

Li J, Lin A, Jiang R, Chen P, Xu C, Hou Y Ann Med Surg (Lond). 2024; 86(1):292-299.

PMID: 38222684 PMC: 10783224. DOI: 10.1097/MS9.0000000000001473.

Evolving Clinical-Translational Investigations of Cerebroprotection in Ischemic Stroke.

Li Y, Schappell L, Polizu C, DiPersio J, Tsirka S, Halterman M J Clin Med. 2023; 12(21).

PMID: 37959180 PMC: 10649331. DOI: 10.3390/jcm12216715.

Effects of time-restricted eating with different eating windows on human metabolic health: pooled analysis of existing cohorts.

Nie Z, Xu J, Cheng Y, Li Z, Zhang R, Zhang W Diabetol Metab Syndr. 2023; 15(1):209.

PMID: 37875984 PMC: 10594936. DOI: 10.1186/s13098-023-01190-y.

Development and validation of risk prediction and neural network models for dilated cardiomyopathy based on WGCNA.

Yu W, Li L, Tan X, Liu X, Yin C, Cao J Front Med (Lausanne). 2023; 10:1239056.

PMID: 37869159 PMC: 10585101. DOI: 10.3389/fmed.2023.1239056.

References

He F, Luo P, Tang T, Zhang F, Fang H, Ji S . Targeted release of stromal cell-derived factor-1α by reactive oxygen species-sensitive nanoparticles results in bone marrow stromal cell chemotaxis and homing, and repair of vascular injury caused by electrical burns. PLoS One. 2018; 13(3):e0194298. PMC: 5847229. DOI: 10.1371/journal.pone.0194298. View

Narita A, Takahara M, Sato D, Ogino T, Fukushima S, Kimura Y . Biodegradable gelatin hydrogels incorporating fibroblast growth factor 2 promote healing of horizontal tears in rabbit meniscus. Arthroscopy. 2011; 28(2):255-63. DOI: 10.1016/j.arthro.2011.08.294. View

Segal M, Shah R, Afzal A, Perrault C, Chang K, Schuler A . Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes. 2005; 55(1):102-9. View

Dimmeler S, Ding S, Rando T, Trounson A . Translational strategies and challenges in regenerative medicine. Nat Med. 2014; 20(8):814-21. DOI: 10.1038/nm.3627. View

Stamm C, Nasseri B, Choi Y, Hetzer R . Cell therapy for heart disease: great expectations, as yet unmet. Heart Lung Circ. 2009; 18(4):245-56. DOI: 10.1016/j.hlc.2008.10.014. View

Tepper O, Galiano R, Capla J, Kalka C, Gagne P, Jacobowitz G . Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002; 106(22):2781-6. DOI: 10.1161/01.cir.0000039526.42991.93. View

Liu Z, Wang H, Wang Y, Lin Q, Yao A, Cao F . The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials. 2012; 33(11):3093-106. DOI: 10.1016/j.biomaterials.2011.12.044. View

Gallagher K, Liu Z, Xiao M, Chen H, Goldstein L, Buerk D . Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest. 2007; 117(5):1249-59. PMC: 1857264. DOI: 10.1172/JCI29710. View

Wollert K, Meyer G, Muller-Ehmsen J, Tschope C, Bonarjee V, Larsen A . Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial. Eur Heart J. 2017; 38(39):2936-2943. DOI: 10.1093/eurheartj/ehx188. View

10.

He J, Liu X, Su C, Wu F, Sun J, Zhang J . Inhibition of Mitochondrial Oxidative Damage Improves Reendothelialization Capacity of Endothelial Progenitor Cells via SIRT3 (Sirtuin 3)-Enhanced SOD2 (Superoxide Dismutase 2) Deacetylation in Hypertension. Arterioscler Thromb Vasc Biol. 2019; 39(8):1682-1698. DOI: 10.1161/ATVBAHA.119.312613. View

11.

Hu X, Huang X, Yang Q, Wang L, Sun J, Zhan H . Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial. Int J Cardiol. 2015; 184:446-451. DOI: 10.1016/j.ijcard.2015.02.084. View

12.

Cheng J, Cui R, Chen C, Du J . Oxidized low-density lipoprotein stimulates p53-dependent activation of proapoptotic Bax leading to apoptosis of differentiated endothelial progenitor cells. Endocrinology. 2007; 148(5):2085-94. DOI: 10.1210/en.2006-1709. View

13.

Xu S, Tao J, Yang L, Zhang E, Boriboun C, Zhou J . E2F1 Suppresses Oxidative Metabolism and Endothelial Differentiation of Bone Marrow Progenitor Cells. Circ Res. 2018; 122(5):701-711. PMC: 6021021. DOI: 10.1161/CIRCRESAHA.117.311814. View

14.

Crespo F, Sobrado V, Gomez L, Cervera A, McCreath K . Mitochondrial reactive oxygen species mediate cardiomyocyte formation from embryonic stem cells in high glucose. Stem Cells. 2010; 28(7):1132-42. DOI: 10.1002/stem.441. View

15.

Antonio N, Fernandes R, Soares A, Soares F, Lopes A, Carvalheiro T . Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. Cardiovasc Diabetol. 2014; 13:101. PMC: 4082424. DOI: 10.1186/1475-2840-13-101. View

16.

Verma S, Kuliszewski M, Li S, Szmitko P, Zucco L, Wang C . C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation. 2004; 109(17):2058-67. DOI: 10.1161/01.CIR.0000127577.63323.24. View

17.

Hare J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S . A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009; 54(24):2277-86. PMC: 3580848. DOI: 10.1016/j.jacc.2009.06.055. View

18.

Roth G, Johnson C, Abajobir A, Abd-Allah F, Abera S, Abyu G . Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017; 70(1):1-25. PMC: 5491406. DOI: 10.1016/j.jacc.2017.04.052. View

19.

Meyer G, Wollert K, Lotz J, Pirr J, Rager U, Lippolt P . Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J. 2009; 30(24):2978-84. DOI: 10.1093/eurheartj/ehp374. View

20.

Folmes C, Nelson T, Martinez-Fernandez A, Arrell D, Lindor J, Dzeja P . Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011; 14(2):264-71. PMC: 3156138. DOI: 10.1016/j.cmet.2011.06.011. View